1. Alzheimer's disease (AD) is a chronic dementia and neurodegenerativ
e disorder affecting the oldest portions of the population, Brains of
AD patients accumulate large amount of the A beta P peptide in amyloid
plaques. 2. The A beta P[1-40] peptide is derived by proteolytic proc
essing from a much larger amyloid precursor protein (APP), and has bee
n circumstantially identified as the toxic principle causing cell dama
ge in the disease. 4. The A beta P[1-40] peptide is able to form quite
characteristic calcium channels in planar lipid bilayers, These chann
els have conductances in the nS range, and can dissipate ion gradients
quickly, The peptide can also cause equivalent cation conductances in
cells. 5. We suggest that amyloid channel blocking agents might be th
erapeutically useful in Alzheimer's Disease, and have constructed mole
cular models of the channels to aid in the design of such compounds.